Skip to main content

Closed

FATE: Fate Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

66thpctl

Volume

0.22×avg

Market Cap

285.57MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Fate Therapeutics, Inc.

FATENASDAQ Global Market·USD·Closed

Fate Therapeutics, Inc.

FATENASDAQ·USD·Closed

$2.45

−2.39%

$2.45

−$0.06 (2.39%)

52W Range

66thpctl

Volume

0.22×avg

Mkt Cap

285.57MUSD

P/E

-2.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings